Considerable evidence also pointed that some RTK-derived tumor proteins avoided downregulation through inefficient Cbl recruitment, loss of Cbl binding sites, Cbl degradation, or by forming fusion proteins that escaped lysosomal degradation. This evidence concerns the gene CBL and neoplasm.